C8-Deficiency in the Mouse: A Useful Animal Model for Human C8 Type II Deficiency

2015 ◽  
pp. 235-244
Author(s):  
Shinobu Tanaka ◽  
Takakazu Suzuki ◽  
Kazuo Moriwaki ◽  
Hiromichi Yonekawa
Keyword(s):  
Type Ii ◽  

2006 ◽  
Vol 17 (7) ◽  
pp. 1147-1154 ◽  
Author(s):  
Mineyoshi Nango ◽  
Kenji Nakamura ◽  
Yukimasa Sakai ◽  
Masao Hamuro ◽  
Saori Tanaka ◽  
...  
Keyword(s):  




2001 ◽  
Vol 2 (3) ◽  
pp. 217-223 ◽  
Author(s):  
Manuel T. Velasquez ◽  
Sam J. Bhathena ◽  
Carl T. Hansen

The spontaneously hypertensive/NIH-corpulent (SHR/N-cp) rat is a genetic animal model that exhibits obesity, metabolic features of hyperinsulinemia, hyperglycemia, and hyperlipidemia, which are characteristic of type II diabetes and mild hypertension. To determine the role of leptin, the protein product of theobgene, in the development of obesity and diabetes in this model, we measured steady-state circulating levels of leptin in obese and lean SHR/N-cp rats and examined the relation between plasma leptin levels and metabolic variables at the stage of established obesity in these animals. Mean fasting plasma leptin concentration was 8-fold higher in obese than in lean rats (p<0.01). This was associated with a 6-fold elevation in plasma insulin in the obese group. Fasting levels of plasma glucose, cholesterol, and triglyceride were all significantly higher in obese rats than in lean controls. Spearman correlation analysis showed a significant positive correlation between plasma leptin concentration and body weight among the animals (r=0.73, p<0.01). Similarly, plasma insulin concentration was significantly correlated with BW in all animals (r=0.54, p<0.05). There was also a significant positive.correlation between plasma leptin and plasma insulin in the entire group (r=0.70, p<0.01). However, this relationship was significant only for lean rats but not for obese rats (r=0.59, p<0.05 for lean rats, and r=0.23, p=NS, for obese rats). Plasma leptin also correlated positively with fasting plasma glucose (r=0.75, p<0.05), total cholesterol (r=0.63, p<0.05), and triglyceride (r=0.67, p <0.05). The marked elevation of plasma leptin in obese SHR/N-cp rats suggests that obesity in this animal model is related to up-regulation of the ob gene. Circulating leptin appears to be one of the best biological markers of obesity and that hyperleptinemia is closely associated with several metabolic risk factors related to insulin resistance in the diabesity syndrome.



2017 ◽  
Vol 65 (4) ◽  
pp. 325-338 ◽  
Author(s):  
Natalia Lubina-Dąbrowska ◽  
Adam Stepień ◽  
Grzegorz Sulkowski ◽  
Beata Dąbrowska-Bouta ◽  
Józef Langfort ◽  
...  


1997 ◽  
Vol 94 (18) ◽  
pp. 9831-9835 ◽  
Author(s):  
Y. C. Li ◽  
A. E. Pirro ◽  
M. Amling ◽  
G. Delling ◽  
R. Baron ◽  
...  




2020 ◽  
Vol 21 (6) ◽  
pp. 2124 ◽  
Author(s):  
Zita Wachal ◽  
Mariann Bombicz ◽  
Dániel Priksz ◽  
Csaba Hegedűs ◽  
Diána Kovács ◽  
...  

High blood glucose and the consequential ischemia-reperfusion (I/R) injury damage vessels of the retina, deteriorating its function, which can be clearly visualized by electroretinography (ERG). The aim of the present study was to evaluate the possible retinoprotective effects of systemic BGP-15, an emerging drug candidate, in an insulin resistant animal model, the Goto-Kakizaki rat, and compare these results with well-known anti-diabetics such as glibenclamide, metformin, and pioglitazone, which even led to some novel conclusions about these well-known agents. Experiments were carried out on diseased animal model (Goto-Kakizaki rats). The used methods include weight measurement, glucose-related measurements—like fasting blood sugar analysis, oral glucose tolerance test, hyperinsulinemic euglycemic glucose clamp (HEGC), and calculations of different indices from HEGC results—electroretinography and Western Blot. Beside its apparent insulin sensitization, BGP-15 was also able to counteract the retina-damaging effect of Type II diabetes comparable to the aforementioned anti-diabetics. The mechanism of retinoprotective action may include sirtuin 1 (SIRT1) and matrix metalloproteinase 9 (MMP9) enzymes, as BGP-15 was able to elevate SIRT1 and decrease MMP9 expression in the eye. Based on our results, this emerging hydroximic acid derivative might be a future target of pharmacological developments as a potential drug against the harmful consequences of diabetes, such as diabetic retinopathy.







Sign in / Sign up

Export Citation Format

Share Document